Have you ever been asked to join a clinical trial for celiac disease? If you have considered participating, what would make you feel safe, informed, and motivated to participate? These…
Continue ReadingThe ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingPeople with celiac disease have a small but significantly increased mortality rate. The finding comes from the largest study of its kind, which used long-term health records of celiac patients in Sweden between 1969 and 2017.
Continue ReadingData from the Nexvax2 study shows celiac patients exposed to gluten react within two hours and experience nausea and vomiting, not the classic lower digestive symptoms commonly associated with celiac disease.
Continue ReadingImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally administered treatment for celiac disease (CD). Latiglutenase was shown to be safe…
Continue ReadingResearchers are collecting blood samples to learn more about the antigens that cause certain T cells to trigger intestinal damage in celiac disease patients. Complete a 30-minute study from home & be compensated $50 for your time.
Continue ReadingThe Center for Celiac Research at Massachusetts General Hospital, MassGeneral Hospital for Children, and the Celiac Research Program at Harvard Medical School, recently launched the Celiac Disease Genomic Environmental Microbiome and…
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...